CL
VRTX icon

CIM LLC’s Vertex Pharmaceuticals VRTX Stock Holding History

CIM LLC’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$281K Hold
629
– – 0.04% 149
2025
Q4 		$285K Sell
629
-2
-0.3% -$862 0.04% 154
2025
Q3 		$247K Sell
631
-2
-0.3% -$836 0.03% 163
2025
Q2 		$282K Buy
633
+158
+33% +$72.8K 0.04% 148
2025
Q1 		$230K Sell
475
-2,719
-85% -$1.27M 0.03% 144
2024
Q4 		$1.29M Buy
3,194
+243
+8% +$113K 0.18% 91
2024
Q3 		$1.37M Buy
2,951
+4
+0.1% +$1.92K 0.2% 79
2024
Q2 		$1.38M Buy
2,947
+42
+1% +$18.2K 0.21% 76
2024
Q1 		$1.21M Buy
2,905
+62
+2% +$26.2K 0.18% 81
2023
Q4 		$1.21M Buy
2,843
+101
+4% +$37.3K 0.19% 78
2023
Q3 		$954K Buy
2,742
+111
+4% +$38.8K 0.18% 84
2023
Q2 		$926K Hold
2,631
– – 0.17% 90
2023
Q1 		$829K Sell
2,631
-3
-0.1% -$900 0.16% 91
2022
Q4 		$768K Sell
2,634
-34
-1% -$10.4K 0.15% 97
2022
Q3 		$838K Sell
2,668
-517
-16% -$149K 0.18% 93
2022
Q2 		$937K Sell
3,185
-125
-4% -$33.5K 0.19% 87
2022
Q1 		$930K Buy
+3,310
New +$786K 0.17% 87
2020
Q3 		– Sell
-2,512
Closed -$729K – 147
2020
Q2 		$729K Sell
2,512
-48
-2% -$13K 0.21% 63
2020
Q1 		$609K Buy
+2,560
New +$587K 0.23% 56

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

CIM LLC's VRTX Position: Q1 2026 in Review

CIM LLC held its Vertex Pharmaceuticals (VRTX) position steady in Q1 2026 at 629 shares worth $281K. The position accounts for 0.04% of the portfolio, ranked #149.

CIM LLC first reported a position in VRTX in Q1 2020 and has held it in 19 quarters since. The position peaked at $1.38M in Q2 2024. 1,688 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • CIM LLC held 629 shares of Vertex Pharmaceuticals worth $281K as of Q1 2026.
  • CIM LLC left its Vertex Pharmaceuticals share count unchanged in Q1 2026.
  • Vertex Pharmaceuticals made up 0.04% of CIM LLC's portfolio in Q1 2026, its #149 holding.
  • CIM LLC first reported a position in Vertex Pharmaceuticals in Q1 2020 and has held it in 19 quarters since.
  • CIM LLC's Vertex Pharmaceuticals position peaked at $1.38M in Q2 2024.
  • 1,688 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on CIM LLC's 13F filing for Q1 2026, filed 18 May 2026.